îæ€çŽ¢
îæ€çŽ¢
î
Zai Lab Ltd
ZLABîãŠã©ãããªã¹ãã«è¿œå
19.150USD
+0.150+0.79%
çµå€Â 07/01, 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
2.12Bæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
詳现ãã£ãŒãã衚瀺
TradingKey åŸè¡šIntraday
1m
30m
1h
D
W
M
D
æ¬æ¥
+0.79%
5æ¥é
+4.25%
1ã¶æ
+12.05%
6ã¶æ
+8.56%
幎åæ¥
+8.56%
1幎é
-45.55%
äž»èŠããŒã¿
19.050å§å€
19.610é«å€
686.16Kåºæ¥é«
æ倱é¡çŽè¿12ã¶æPER
æ倱é¡äºæ³PER
--çŽè¿12ã¶æé
åœ
0.62%売買å転ç
19.000åæ¥çµå€
18.790å®å€
9.61M売買代é
æ倱é¡æ ªäŸ¡åçç
2.96PBRïŒæ ªäŸ¡çŽè³ç£åçïŒ
0.00%çŽè¿12ã¶æé
åœå©åã
-15.70%ç·è³ç£å©çç
44.34052é±é«å€
0.63åºæ¥é«æ¯ç%
-257.10MçŽå©ç
110.64Mæ ªåŒæ°
-1.61511æ ªåœããå©çïŒEPSïŒ
0.81ããŒã¿å€
-24.19%èªå·±è³æ¬å©çç
15.96052é±å®å€
4.32%æ¯ãå¹
61.72%ç²å©çç
2.12Bæ䟡ç·é¡
5.27ãªã¹ã¯ãªã¿ãŒã³
2.05%ãªã¹ã¯ç
TradingKeyã®Zai Lab Ltdã®æ ªåŒã¹ã³ã¢î
é貚: USD æŽæ°æå»: 2026-06-30äž»èŠã€ã³ãµã€ã
Zai Lab Ltdã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯æ¯èŒçéåžžã«å¥å šã§ããæé·ã®å¯èœæ§ã¯é«ãã§ããããªã¥ãšãŒã·ã§ã³ã¯é©æ£äŸ¡æ Œãšè©äŸ¡ãããŠããŸããå»è¬åæ¥çã§ã®é äœã¯157äž57äœã§ããæ©é¢æè³å®¶ä¿æçã¯éåžžã«é«ãã§ããéå»1ãæéã«è€æ°ã®ã¢ããªã¹ããè²·ããšè©äŸ¡ããæé«ç®æšæ ªäŸ¡ã¯33.88ãšãããŠããŸããäžæçã«ã¯ãæ ªäŸ¡ã¯å®å®æšç§»ãšäºæ³ãããŸããå瀟ã¯éå»1ãæéãæ ªåŒåžå Žã§å¥œèª¿ãªããã©ãŒãã³ã¹ã瀺ããŠãããããã¯å匷ããã¡ã³ãã¡ã³ã¿ã«ãºãšãã¯ãã«ã«ã«è£ä»ããããŠããŸããæ ªäŸ¡ã¯æ¯æç·ãšæµæç·ã®éã§æšªã°ãæšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
Zai Lab Ltdã®ã¹ã³ã¢î°î°
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
ã¬ãŒããŒãã£ãŒã
çŸåš
ååå€
ã¡ãã£ã¢å ±é
éå»24æé
å ±éã¬ãã«
éåžžã«äœã
éåžžã«é«ã
äžç«
Zai Lab Ltdã®æ³šç®ãã€ã³ã
匷ã¿ãªã¹ã¯
Zai Lab Ltd is a holding company primarily engaged in biopharmaceuticals. The Company is committed to addressing the unmet medical needs in the fields of tumors, autoimmune diseases, infectious diseases and central nervous system diseases through product discovery, development and commercialization. The Company has a series of patented drug candidates from the discovery stage to the late clinical project. These include ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others.
é«æé·
å瀟ã®åçã¯éå»3幎éã«ãããçå®ã«å¢å ããŠããã幎平åã§72.52%ã®æé·çã瀺ããŠããŸãã
å²å®
å瀟ã®ææ°ã®PEã¯-11.76ã§ãéå»3幎éã®æ°Žæºãšæ¯èŒããŠå®å€åã«ãããŸãã
ãã³ã»ããã³ãä¿æ
ã¹ã¿ãŒæè³å®¶ãã³ã»ããã³ã¯æ¬éæã1.67Mæ ªä¿æããŠããŸãã
ã¢ããªã¹ãè©äŸ¡
12
人ã®ã¢ããªã¹ãäºæ³ã«åºã¥ã
è²·ã
çŸåšã®è©äŸ¡
33.876
ç®æšæ ªäŸ¡
+78.30%
äžæäœå°
Zai Lab Ltd ãã¥ãŒã¹
ææ°æ
å ±ããåŸ
ã¡ãã ãã...
財åææšî
EPS
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
ç·å£²äžé«
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
Zai Lab Ltdã®äŒæ¥æ å ±î
Zai Lab Ltd is a holding company primarily engaged in biopharmaceuticals. The Company is committed to addressing the unmet medical needs in the fields of tumors, autoimmune diseases, infectious diseases and central nervous system diseases through product discovery, development and commercialization. The Company has a series of patented drug candidates from the discovery stage to the late clinical project. These include ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others.
äŒæ¥ã³ãŒãZLAB
äŒæ¥åZai Lab Ltd
æé«çµå¶è²¬ä»»è
ãCEOãDu (Ying)
ãŠã§ããµã€ãhttps://www.zailaboratory.com/
é¢é£éèåå
-0.64%
-0.05%
-2.95%
-0.23%
-2.41%
-1.64%
-0.22%
+1.75%
-0.29%
-0.79%
+0.26%
-2.00%
-2.10%
-2.41%
+1.68%
0.00%
+0.19%
-1.97%
+0.06%
-0.44%人æ°éæ
52247.700
-6.600Â (-0.01%)
29789.400
-9.900Â (-0.03%)
7477.600
+2.100Â (+0.03%)
15324.000
-31.000Â (-0.20%)
68974.000
-511.000Â (-0.73%)
6271.300
-4.100Â (-0.07%)
67.766
-0.202Â (-0.30%)
294.380
+5.020Â (+1.73%)
197.580
-2.510Â (-1.25%)
4041.370
+10.600Â (+0.26%)
ãããã質å
Zai Lab LtdïŒZLABïŒã®çŸåšã®æ ªäŸ¡ã¯ãããã§ããïŒ
îZai Lab LtdïŒZLABïŒã®çŸåšã®æ ªäŸ¡ã¯19.15ã§ãã
Zai Lab Ltdã®ãã£ãã«ãŒã·ã³ãã«ã¯äœã§ããïŒ
îZai Lab Ltdã®ãã£ãã«ãŒã·ã³ãã«ã¯ZLABã§ãã
Zai Lab Ltdã®52é±é«å€ã¯ãããã§ããïŒ
îZai Lab Ltdã®52é±é«å€ã¯44.34ã§ãã
Zai Lab Ltdã®52é±å®å€ã¯ãããã§ããïŒ
îZai Lab Ltdã®52é±å®å€ã¯15.96ã§ãã
Zai Lab Ltdã®æ䟡ç·é¡ã¯ãããã§ããïŒ
îZai Lab Ltdã®æ䟡ç·é¡ã¯2.12Bã§ãã
Zai Lab Ltd (ZLAB) ã®çŸåšã®è©äŸ¡ã¯ãè²·ããããããŒã«ãããã売ããã®ã©ãã§ããïŒ
îã¢ããªã¹ãã«ãããšãZai Lab LtdïŒZLABïŒã®ç·åè©äŸ¡ã¯è²·ãã§ãç®æšæ ªäŸ¡ã¯33.88ã§ãã
Zai Lab Ltd (ZLAB) ã®1æ ªåœããå©çïŒEPS TTMïŒã¯ãããã§ããïŒ
îZai Lab LtdïŒZLABïŒã®1æ ªåœããå©çïŒEPS TTMïŒã¯-1.60ã§ãã